SUPN icon

Supernus Pharmaceuticals
SUPN

Overview Fund Activity

119 hedge funds and large institutions have $491M invested in Supernus Pharmaceuticals in 2015 Q1 according to their latest regulatory filings, with 25 funds opening new positions, 45 increasing their positions, 31 reducing their positions, and 13 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
119
Holders Change
+12
Holders Change %
+11.21%
% of All Funds
3.17%
Holding in Top 10
7
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+75%
% of All Funds
0.19%
New
25
Increased
45
Reduced
31
Closed
13
Calls
$4.93M
Puts
$2.67M
Net Calls
+$2.26M
Net Calls Change
+$1.25M

Top Buyers

1
CCM
Consonance Capital Management
New York
$43.1M
2
KCM
Kennedy Capital Management
Missouri
$8.1M
3
ACM
Ashford Capital Management
Delaware
$8.22M
4
CWG
C WorldWide Group
Denmark
$4.59M
5
NC
Northpointe Capital
Michigan
$14.6M

Top Sellers

1
AAP
Ardsley Advisory Partners
Connecticut
$11.9M
2
A
Abingworth
United Kingdom
$27.8M
3
MRM
Michael R. Murphy
$32M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$12.8M
5
TC
TFS Capital
Pennsylvania
$1.74M
Name Holding Trade Value Shares
Change 		Shares
Change %
SCM
126
Stevens Capital Management
Pennsylvania
– -$250K -30,115 Closed
CCMH
127
Cornerstone Capital Management Holdings
New York
– -$198K -23,800 Closed
HCM
128
Highbridge Capital Management
New York
– -$193K -23,270 Closed
PA
129
Perceptive Advisors
New York
– -$185K -22,285 Closed
CIA
130
Capital Impact Advisors
Massachusetts
– -$139K -16,796 Closed
CSS
131
Cubist Systematic Strategies
Connecticut
– -$135K -16,252 Closed
DTL
132
Dynamic Technology Lab
Singapore
– -$134K -16,178 Closed
2 3 4 5
6